Vanguard Group Inc Neogenomics Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 14,211,019 shares of NEO stock, worth $195 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,211,019
Previous 14,169,665
0.29%
Holding current value
$195 Million
Previous $229 Million
2.56%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding NEO
# of Institutions
280Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$273 Million0.01% of portfolio
-
Brown Advisory Inc9.67MShares$133 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$94.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$86.2 Million0.06% of portfolio
-
State Street Corp Boston, MA4.9MShares$67.2 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.73B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...